Concepedia

Kyle S. Michel

KS

5

Publications

135

Citations

5

H-Index

2014

Active since

Affiliations

Biothera (United States)(Current)

ProThera Biologics (United States)

California Institute for Medical Research

FuelCell Energy (United States)

Biota Pharmaceuticals (United States)

Kyle S. Michel is an author at Biothera (United States) specializing in medicine, immunotherapy, and immunology.

Top concepts

Publications per year

2014–2023

5

Publications

5

Whole glucan particles as a vaccine against murine aspergillosis

Karl V. Clemons, Michael E. Danielson, Kyle S. Michel et al. · Journal of Medical Microbiology · 2014 · 41 citations

, , +11

Imprime PGG-Mediated Anti-Cancer Immune Activation Requires Immune Complex Formation

Anissa Chan, Adria Bykowski Jonas, Xiaohong Qiu et al. · PLoS ONE · 2016 · 40 citations · Full text

, , +20

Whole glucan particles as a vaccine against systemic coccidioidomycosis

Karl V. Clemons, Mary A. Antonysamy, Michael E. Danielson et al. · Journal of Medical Microbiology · 2015 · 21 citations

, , +14

Imprime PGG Enhances Anti-Tumor Effects of Tumor-Targeting, Anti-Angiogenic, and Immune Checkpoint Inhibitor Antibodies

Anissa Chan, Takashi Kangas, Xiaohong Qiu et al. · Frontiers in Oncology · 2022 · 17 citations · Full text

Dectin-1 multimerization and signaling depends on fungal β-glucan structure and exposure

Eduardo Anaya, Akram Etemadi Amin, Michael J. Wester et al. · Biophysical Journal · 2023 · 16 citations · Full text

, , +10

Rows per page

1–5 of 5